Psychiatric Drugs Explained

Häftad, Engelska, 2022

404 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting. Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them. A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.

Produktinformation

Utgivningsdatum:2022-05-06
Mått:152 x 229 x 15 mm
Vikt:600 g
Format:Häftad
Språk:Engelska
Antal sidor:356
Upplaga:7
Förlag:Elsevier Health Sciences
ISBN:9780702083907

Utforska kategorier

Mer om författaren

A professor of Psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology, and has authored more than 200 peer-reviewed articles, 200 other pieces, and 20 books, including The Antidepressant Era and The Creation of Psychopharmacology from Harvard University Press, The Psychopharmacologists Volumes 1-3 and Let Them Eat Prozac from New York University Press, and Mania from Johns Hopkins University Press.David's latest book, Pharmageddon, documents the riveting and terrifying story of how pharmaceutical companies have hijacked healthcare in America and the life-threatening results.David's main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture.

Innehållsförteckning

Section 1 Management of the psychoses1 The antipsychotics2. Antipsychotic side effects and their managementSection 2 Management of depression3. The antidepressants4. Side effects of antidepressantsSection 3 Management of bipolar disorders5. Management of acute bipolar disorder6. Mood-stabilisersSection 4 Stimulants & Drugs for children7. Stimulants & Drugs for childrenSection 5 Management of anxiety8. The anxiety disorders10. Benzodiazepine anxiolytics11. Anxiolysis and the serotonin system12. Beta-blockers and anxietySection 6 Management of sleep disorders and insomnia13. Sleep disorders and insomnia14. Non-pharmacological management of insomnia15. Hypnotics16. SedativesSection 7 Management of cognitive impairment17. Cognitive enhancement and the dementias18. Cognitive enhancement and neuroprotectionSection 8 Management of sexual difficulties19. The range of sexual difficulties20. Effects of drugs on aspects of sexual functioningSection 9 Management of dependence and withdrawal21. Dependence & Withdrawal22. Dependence & Craving23. Dependence & Protracted WithdrawalSection 10 Consent, abuse and liability24. Consent25. Pharmacological abuseSection 11 The marketing of tranquillity26. The ethical industry27. Evidence-biased care28. Marketing & Risk29. From healthcare to pharmageddon